Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

50–60yrs). : >1:1. Relative risk in 1st-degree relatives is 6≈. Presentation Stinking stools/steatorrhoea; diarrhoea; abdominal pain; bloating; nau- sea + vomiting; aphthous ulcers; angular stomatitis (p327, fi g 8.5); weight; fatigue; weakness; osteomalacia; failure to thrive (children). ~30% less severe: may mimic IBS. Diagnosis Hb; RCDW (p325); B12, ferritin. Antibodies: anti-transglutaminase is single preferred test (but is an IgA antib ody—check IgA levels to exclude subclass defi - ciency). Where serology positive or high index of suspicion proceed to duodenal biopsy while on a gluten-containing diet: expect subtotal villous atrophy, intra-epithelial WBCS + crypt hyperplasia. Where doubt persists, HLA DQ2 and DQ8 genotyping may help. Treatment Lifelong gluten-free diet—patients become experts. Rice, maize, soya, potatoes, and sugar are OK. Limited consumption of oats (≤50g/d) may be toler- ated in patients with mild disease. Gluten-free biscuits, fl our, bread, and pasta are prescribable. Monitor response by symptoms and repeat serology.9 Complications Anaemia; dermatitis herpetiformis (OHCS p588); osteopenia/os- teoporosis; hyposplenism (off er ‘fl u and pneumococcal vaccinations); GI T-cell lymphoma (rare; suspect if refractory symptoms or weight);  risk of malignancy (lymphoma, gastric, oesophageal, colorectal); neuropathies. Irritable bowel syndrome (IBS) IBS denotes a mixed group of abdominal symptoms for which no organic
